US approves HIV home test kit


An HIV home test kit has been approved for marketing in the US. The ‘OraQuick’ kit from US diagnostics firm OraSure, is already in use by clinics, but until now the company has not been allowed to market it for home use.

Users collect an oral sample by swabbing their gums and putting the swab into a buffer solution. The kit then provides a result in 20–40 minutes.

The Food and Drug Administration says that the test should not be considered conclusive. It gets the answer right 92% of the time when the user is infected and 99.98% when they aren't. Despite this shortcoming, the FDA adds: ‘The test has the potential to identify large numbers of previously undiagnosed HIV infections, especially if used by those unlikely to use standard screening methods.’

OraSure is planning to launch the home test version of the kit in October.


Related Content

Chemistry World podcast - January 2014

15 January 2014 Podcast | Monthly

news image

This month, we examine the controversy surrounding the Turin shroud and explore the history of crystallography

First HIV drug approved as prevention

17 July 2012 Business

news image

Truvada tablets can reduce the risk of infection for an HIV-negative person

Most Read

Better batteries with pure lithium anodes

28 July 2014 Research

news image

Protective carbon nanosphere coating overcomes lithium problems, pointing the way to improved capacity

Takeover battle pushes Allergan to cut R&D jobs

28 July 2014 Business

news image

Besieged by serially acquisitive Valeant, the Botox maker will lay off 1500 staff to propel earnings growth

Most Commented

Bubble wrap could send lab costs packing

23 July 2014 Research

news image

Potential bubbles up across wide range of uses as storage and test vessels, especially for poor countries

Relativity behind mercury's liquidity

21 June 2013 Research

news image

First evidence that relativistic effects are indeed responsible for mercury's low melting point